Accéder au contenu
MilliporeSigma

Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain Injury.

Frontiers in molecular neuroscience (2017-06-13)
Winfried Neuhaus, Tobias Krämer, Anja Neuhoff, Christina Gölz, Serge C Thal, Carola Y Förster
RÉSUMÉ

The blood-brain barrier (BBB) is damaged during ischemic insults such as traumatic brain injury or stroke. This contributes to vasogenic edema formation and deteriorate disease outcomes. Enormous efforts are pursued to understand underlying mechanisms of ischemic insults and develop novel therapeutic strategies. In the present study the effects of PPARα agonist WY-14643 were investigated to prevent BBB breakdown and reduce edema formation. WY-14643 inhibited barrier damage in a mouse BBB

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Solution saline dans un tampon phosphate de Dulbecco, Modified, without calcium chloride and magnesium chloride, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Milieu d'Eagle modifié par Dulbecco (DMEM) à teneur élevée en glucose, With 4500 mg/L glucose, L-glutamine, and sodium bicarbonate, without sodium pyruvate, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, pH 7, ≥98%
Sigma-Aldrich
Triton X-100, for molecular biology
Sigma-Aldrich
Collagène from human placenta, Bornstein and Traub Type IV, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Z-Leu-Leu-Leu-al, ≥90% (HPLC)
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, pH 7, ≥98%
Sigma-Aldrich
Lactacystin, ≥90% (HPLC)
Sigma-Aldrich
GW6471, ≥98% (HPLC)
Sigma-Aldrich
Plasminogen activator inhibitor 1 (PAI-1) human, recombinant, expressed in E. coli, ≥90% (SDS-PAGE)
Sigma-Aldrich
Z-Leu-Leu-Glu-7-amido-4-methylcoumarin, ≥95%, solid
Sigma-Aldrich
Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin, protein C substrate